设计,合成和生物评估作为强效抗菌剂的膜活性cannabichromene衍生物
Bin Long1, Na Wang1, Zhangqun Hou2
1Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, 610106, China.
European journal of medicinal chemistry
|June 28, 2025
概括
研究人员开发了新的大麻烯衍生物来对抗多药耐药细菌感染. 化合物11F有效向细菌膜,在临床前模型中显示出强大的抗菌活性和出色的安全性.
科学领域:
- 药用化学 医学化学
- 发现抗微生物药物 发现抗微生物药物
- 分子生物学分子生物学
背景情况:
- 耐多药性 (MDR) 细菌感染构成了严重的全球健康威胁.
- 迫切需要具有独特机制的新型抗菌剂.
- 抗微生物 (AMP) 为新药设计提供了一个有希望的模板.
研究的目的:
- 理性地设计和合成新型阴性两性大麻烯 (CBC) 衍生物.
- 为了优化CBC结构,提高水性和更广泛的抗菌谱.
- 为了识别一种化合物,对MDR病原体有强烈的活性.
主要方法:
- 合成和结构优化CBC衍生品.
- 确定针对格拉姆阳性和格拉姆阴性细菌的最小抑制度 (MIC).
- 机械研究包括膜结合测定,分子动力学模拟和反应性氧物种 (ROS) 测量.
- 在小鼠MRSA败血症模型中的体内疗效评估.
主要成果:
- 化合物11F是一种CBC衍生物,对MDR病原体 (MICs:0.25-8μg/mL) 显示出强烈的活性,其性能优于万科米辛和塞夫塔齐迪姆.
- 11F通过结合脂糖醇 (PG) 破坏细菌膜,导致透和细胞质泄漏.
- 分子动力学模拟证实了膜准机制.
- 协同作用的ROS积累增强了杀菌作用.
- 化合物11F显示出低血解和细胞毒性,具有显著的体内疗效 (MRSA败血症模型中减少98.8%).
结论:
- 化合物11F是新一类膜活性抗菌剂的非常有前途的领先候选者.
- 优化的CBC支架为开发针对MDR感染的新疗法提供了可行的策略.
- 对于治疗具有挑战性的细菌感染,需要对11F进行进一步的临床开发.
相关概念视频
Antimicrobial Effectiveness
175
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
175
Biological Methods for Microbial Control
214
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
214
Biosynthesis of Lipids
105
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
105


